ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Bone-Targeting HUVEC-Derived Exosomes Containing miR-503-5p for Osteoporosis Therapy

Huang, Haoqiang; Feng, Xinting; Feng, Ye; Peng, Zhen; Jiao, Chunmeng; Chen, Hui; Fu, Chieh Ru; Xu, Feng; Wang, Yitao; Su, Xiaoping*; Luo, Zhiwen*; Wang, Qing*复旦大学; 广东药学院; 上海交通大学
ACS Applied Nano Materials2023-12-12DOI: 10.1021/acsanm.3c05056
4阅读
引用收藏
分享

摘要

Osteoporosis (OP) is a systemic bone disease characterized by decreased bone mass, damaged bone microstructure, increased bone fragility, and increased risk of fractures. It is more common in postmenopausal women and elderly people. The development of drugs with a high bone-targeting ability is urgently needed. We prepared a bioactive nanoparticle that modified the exosomes derived from human umbilical vein endothelial cells (HUVEC-Exo(miR-503-high)) to contain a large amount of miR-503-5p, with a diameter range of 30-150 nm. The HUVEC-Exo(miR-503-high) that we constructed had the same characteristics as ordinary exosomes and could bind to osteoblasts/osteoclasts in vitro. Moreover, they exhibited better bone-targeting ability than exosomes derived from other sources of bone marrow stromal cells in vivo. Bioinformatics analysis showed that miR-503-5p is strongly associated with bone-related pathways. In vitro experiments showed that HUVEC-Exo(miR-503-high) effectively inhibited osteoclast differentiation and promoted osteogenic differentiation. In vivo experiments showed that injecting HUVEC-Exo(miR-503-high) into OP mice significantly increased bone density and prevented OP. HUVEC-Exo(miR-503-high) can be used for bone-targeted therapy of OP, providing an approach to the clinical prevention and treatment of OP.

学科与关键词

关键词
osteoporosisengineered exosomesmiRNAbone targetingnanomaterialHUVECosteoclastosteogenic
相关
加载中…
  • BMSC-derived exosomal miR-27a-3p and miR-196b-5p regulate bone remodeling in ovariectomized rats
    Lai, Guohua; Zhao, Renli; Zhuang, Weida; Hou, Zuoxu; Yang, Zefeng; He, Peipei; Wu, Jiachang*; Sang, Hongxun*PEErJ, 2022, 10: e13744.被引 9
  • Circulating miR-338 Cluster activities on osteoblast differentiation: Potential Diagnostic and Therapeutic Targets for Postmenopausal Osteoporosis
    Chujiao, Lin; Shuaitong, Yu; Runze, Jin; Yao, Xiao; Minghui, Pan; Fei, Pei; Xiaojing, Zhu; Huarong, Huang; Zunyi, Zhang; Shuo, Chen; Huan, Liu; Zhi, Chen2019, 9(13): 3780-3797.被引 23
  • Bioactive glass nanoparticles inhibit osteoclast differentiation and osteoporotic bone loss by activating lncRNA NRON expression in the extracellular vesicles derived from bone marrow mesenchymal stem cells
    Yang, Zhengyu; Liu, Xiaodong; Zhao, Fujian; Yao, Mengyu; Lin, Zefeng; Yang, Zhen; Liu, Cong; Liu, Yuwei; Chen, Xiaofeng*; Du, Chang*Biomaterials, 2022, 283: 121438.被引 26
查看全部 →

发表信息

论文状态
公开发表
期刊
ACS Applied Nano Materials
发表日期
2023-12-12
卷期
第 7 卷, 第 1 期
页码
1156-1169
DOI
10.1021/acsanm.3c05056
成果收录
SCIE
资助标注
Suzhou People's Livelihood Science and Technology [SYS2020065]; Kunshan High-Level Medical Talent Team Project [01201801]; Kunshan Traditional Chinese Medicine Technology Development Fund [KZYY2203]; Youth Science Fund of Kunshan Traditional Chinese Medicine Hospital [2022QNJJ06]

作者

  • H

    Huang, Haoqiang (第一作者)

  • F

    Feng, Xinting

    fudan univ

查看全部 12 位作者收起作者
  • F

    Feng, Ye

    xuzhou med univ

  • P

    Peng, Zhen

    shanghai jiao tong univ

  • J

    Jiao, Chunmeng

    guangdong pharmaceut univ

  • C

    Chen, Hui

    fudan univ

  • F

    Fu, Chieh Ru

    fudan univ

  • X

    Xu, Feng

  • W

    Wang, Yitao

  • S

    Su, Xiaoping (通讯)

    guangxi med univ

  • L

    Luo, Zhiwen (通讯)

    fudan univ

  • W

    Wang, Qing (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417